ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026
Development of a Glycated Albumin-Based Algorithm to Evaluate Diabetic Retinopathy in Adults with Type 2 Diabetes: A Cross-Sectional Study at a Hospital-Affiliated Physical Examination Center.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early diagnosis and management of diabetic retinopathy are essential to avoid vision impairment. We explored different glycated albumin levels in patients with or without diabetic retinopathy, and further constructed a glycated albumin based-model to predict the presence of diabetic retinopathy. Methods: This cross-sectional study, which was conducted at a physical examination center from June 2022 to June 2024, collected clinical information, laboratory test results, and information on diabetic retinopathy from type 2 diabetes adults. Least absolute shrinkage and selection operator regression was applied to select the variables associated with diabetic retinopathy, with optimal threshold determined by receiver operating characteristic curve analysis. Eight machine learning algorithms, including eXtreme Gradient Boosting, logistic regression, Light Gradient-Boosting Machine, random forest, adaptive boosting, K-nearest neighbors, support vector machine, and Gaussian naïve Bayes, were compared to select the model with the best performance in predicting the risk of diabetic retinopathy. Results: Of the 809 eligible patients, 85 (10.5%) and 724 (89.5%) had or had no diabetic retinopathy. Glycated albumin and glycated hemoglobin levels were higher in patients with diabetic retinopathy than in those without diabetic retinopathy. Glycated albumin had satisfactory performance for predicting diabetic retinopathy (area under the curve 0.657 at a threshold of 18.0%). Multivariate regression logistic analysis revealed that glycated albumin was independently correlated with diabetic retinopathy. Machine learning algorithm analysis illustrated that the random forest model had the best performance in predicting the presence of diabetic retinopathy (area under the curve 0.648 and 0.725 in validation and final test sets, respectively). Both calibration curve and decision curve analyses suggested high clinical predication value and applicability for this model. Conclusion: High glycated albumin levels were associated with diabetic retinopathy in patients with type 2 diabetes. A novel prediction model based on glycated albumin could be used to predict the risk of diabetic retinopathy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.